Abstract
The progress that has been made in organic synthesis via the reactions of hydrazones with lead tetraacetate, mainly since 1970, is presented in this review. Thus, the synthesis of various compounds, as gem-azoacetates, azo and diazo compounds, acylhydrazines, alkenes, oxadiazolines, triazoles, pyrazoles, indazoles and dibenzazepinones will be discussed. Special emphasis is given in a synthetically useful new rearrangement that takes place in LTA oxidations of N-acylhydrazones of ohydroxyaryl ketones and leads to high yield synthesis of 1,2-diacylbenzenes, oacylarylcarboxylic esters, o-acylbenzoyl bromides, 1,2,3- triacylbenzenes, 1,2,3,4- tetraacylbenzenes, o-acylbenzaldehydes and o-phthalaldehyde. Finally, some of the applications of hydrazones and their derivatives are discussed.
Keywords: Hydrazones, Lead Tetraacetate, dibenzazepinones, 1,2,3-triacylbenzenes, AZOACETOXY COMPOUNDS, 3-hydrazino-6-chloropyridazine
Current Organic Chemistry
Title: Reactions of Hydrazones with Lead Tetraacetate in Organic Synthesis
Volume: 6 Issue: 11
Author(s): Antigoni Kotali
Affiliation:
Keywords: Hydrazones, Lead Tetraacetate, dibenzazepinones, 1,2,3-triacylbenzenes, AZOACETOXY COMPOUNDS, 3-hydrazino-6-chloropyridazine
Abstract: The progress that has been made in organic synthesis via the reactions of hydrazones with lead tetraacetate, mainly since 1970, is presented in this review. Thus, the synthesis of various compounds, as gem-azoacetates, azo and diazo compounds, acylhydrazines, alkenes, oxadiazolines, triazoles, pyrazoles, indazoles and dibenzazepinones will be discussed. Special emphasis is given in a synthetically useful new rearrangement that takes place in LTA oxidations of N-acylhydrazones of ohydroxyaryl ketones and leads to high yield synthesis of 1,2-diacylbenzenes, oacylarylcarboxylic esters, o-acylbenzoyl bromides, 1,2,3- triacylbenzenes, 1,2,3,4- tetraacylbenzenes, o-acylbenzaldehydes and o-phthalaldehyde. Finally, some of the applications of hydrazones and their derivatives are discussed.
Export Options
About this article
Cite this article as:
Kotali Antigoni, Reactions of Hydrazones with Lead Tetraacetate in Organic Synthesis, Current Organic Chemistry 2002; 6 (11) . https://dx.doi.org/10.2174/1385272023373761
DOI https://dx.doi.org/10.2174/1385272023373761 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Delivery of Intracellular-Acting Biologics in Pro-Apoptotic Therapies
Current Pharmaceutical Design Aluminum Vaccine Adjuvants: Are they Safe?
Current Medicinal Chemistry Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma
Current Neuropharmacology Angiogenesis in Glioblastoma Multiforme: Navigating the Maze
Anti-Cancer Agents in Medicinal Chemistry Stable Expression of the Sodium/Iodide Symporter (NIS) for anti-Cancer Gene Therapy of Glioma Cells Using a Third Generation Self-Inactivating Lentiviral Vector System in Combination with 211At
Current Radiopharmaceuticals Editorial (Thematic Issue: New Therapeutic Approaches for the Treatment of Glioblastoma)
Current Cancer Drug Targets Perspective of MiRNAs in Clinical Glioblastoma Research
Current Signal Transduction Therapy Novel Possible Pharmaceutical Research Tools: Stem Cells, Gene Delivery and their Combination
Current Pharmaceutical Design A Connecting Switch Among Aging, Diabetes and Tumor: Avenue Leading to Cancer Therapeutics
Current Cancer Therapy Reviews Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders
Current Pharmaceutical Design Identification of Small Molecule Sulfonic Acids as Ecto-5'-Nucleotidase Inhibitors
Medicinal Chemistry Epigenetic Regulation of Epithelial-Mesenchymal Transition by Hypoxia in Cancer: Targets and Therapy
Current Pharmaceutical Design Challenges in the Design of Clinically Useful Brain-targeted Drug Nanocarriers
Current Medicinal Chemistry New Benzimidazole-Derived Isothioureas as Potential Antileukemic Agents - Studies <i>In Vitro</i>
Medicinal Chemistry Genomic Signatures for Individualized Treatment of Malignant Tumors
Current Drug Discovery Technologies IAPs as a Target for Anticancer Therapy
Current Cancer Drug Targets Oncogene-Directed Therapies as Modulators of Cancer Coagulopathy, Angiogenesis and Tumor-Vascular Interface
Current Signal Transduction Therapy Astrocytic Target Mechanisms in Epilepsy
Current Medicinal Chemistry Human Sirtuins: An Overview of an Emerging Drug Target in Age-Related Diseases and Cancer
Current Drug Targets Receptor-Specific Peptides for Targeting of Liposomal, Polymeric, and Dendrimeric Nanoparticles in Cancer Diagnosis and Therapy
Current Molecular Imaging (Discontinued)